- December 2016
Joao Incio on mechanisms to explain why obesity promotes cancer.
- November 2016
Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer.
- October 2016
Ruth Muschel on a new target for treatments for colorectal cancer.
- September 2016
Freddie Hamdy on the effectiveness of treatments for prostate cancer.
- August 2016
Moshe Oren discusses the effects of the microenvironment on cancer cells.
- July 2016
Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
- June 2016
Key advances in clinical trials.
- May 2016
Mark Lemmon on the underlying biochemistry of cancer.
- April 2016
Roger Stupp on using alternating electric fields as treatment.
- March 2016
Charlotte Vrinten on public perception of deaths from cancer.
- February 2016
Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
- December 2015/January 2016
Nazneen Rahman on germline genetic screening in ovarian cancer.
EJC News Focus – April 2013
What impact will an ageing population have in cancer?
The increasing burden of cancer in an ageing population is widely accepted, but more detailed discussion of the implications for patients, oncologists and healthcare systems is sometimes lacking. Elderly patients may of course need specific treatment approaches, but experts are calling for a more wide-ranging debate on measures that need to be put in place now to meet the needs of an ageing population. In this month's EJC News Focus, Richard Marais, David Cameron, Mary O'Brien, Roger Stupp, Manuela Schmidinger and Jan Willem Coebergh tell Helen Saul that it's time to re-look at screening and treatment guidelines, at survivorship issues, and the structures that will be needed to deal with co-morbidity.